Give Kids a Chance Act of 2023
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Give Kids a Chance Act of 2023
This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.
Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.
The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2897: Give Kids a Chance Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-2897/
"S. 2897: Give Kids a Chance Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2897/.
S. 2897, 118th Cong. (2026), https://openamerica.io/bill/118-S-2897/.
[S. 2897: Give Kids a Chance Act of 2023](https://openamerica.io/bill/118-S-2897/)